Profil
Jacob Lange Moresco is currently Director at Step Pharma SAS and Associate at Sunstone Capital A since 2010.
Education includes graduate and doctorate degrees from the Technical University of Denmark.
Postes actifs de Jacob Lange Moresco
| Sociétés | Poste | Début |
|---|---|---|
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board. | Analyste en capital-investissement | 01/06/2010 |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Directeur/Membre du Conseil | - |
Formation de Jacob Lange Moresco
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
















